The effects of adrenergic agents on the humoral immune response / by Homer, John T.,
INFORMATION TO USERS
This material was produced from a microfilm copy of the original document. While 
the most advanced technological means to photograph and reproduce this document 
have been used, the quality is heavily dependent upon the quality of the original 
submitted.
The following explanation of techniques is provided to help you understand 
markings or patterns which may appear on this reproduction.
1. The sign or "target" for pages apparently lacking from the document 
photographed is "Missing Page(s)". If it was possible to obtain the missing 
page(s) or section, they are spliced into die film along with adjacent pages. 
This may have necessitated cutting thru an image and duplicating adjacent 
pages to insure you complete continuity.
2. When an image on the film is obliterated with a large round black mark, it 
is an indication that the photographer suspected that the copy may have 
moved during exposure and thus cause a blurred image. You will find a 
good image of the page in the adjacent frame.
3. When a map, drawing or chart, etc., was part of the material being 
photographed the photographer followed a definite method in 
"sectioning" the material. It is customary to begin photoing at the upper 
left hand corner of a large sheet and to continue photoing from left to 
right in equal sections with a small overlap. If necessary, sectioning is 
continued again -  beginning below the first row and continuing on until 
complete.
4. The majority of users indicate that the textual content is of greatest value, 
however, a somewhat higher quality reproduction could be made from 
"photographs" if essential to the understanding of the dissertation. Silver 
prints of "photographs" may be ordered at additional charge by writing 
the Order Department, giving the catalog number, title, author and 
specific pages you wish reproduced.
5. PLEASE NOTE: Some pages may have indistinct print. Filmed as 
received.
Xerox University Microfiims
300 North Zeeb Road
Ann Arbor, Michigan 48106
73- 23,941
HOMER, John Terry, 1934-
THE EFFECTS OF ADRENERGIC AGENTS ON THE HUMORAL 
IMMUNE RESPONSE.
The University of Oklahoma, Ph.D., 1973 
Health Sciences, immunology
University Microfilms, A XEROX Company, Ann Arbor, Michigan
THIS DISSERTATION HAS BEEN MICROFILMED EXACTLY AS RECEIVED.
THE UNIVERSITY OF OKLAHOMA 
GRADUATE COLLEGE
THE EFFECTS OF ADRENERGIC AGENTS ON THE 
HUMORAL IMMUNE RESPONSE
A DISSERTATION 
SUBMITTED TO THE GRADUATE FACULTY 
in partial fulfillment of the requirements for the
degree of 
DOCTOR OF PHILOSOPHY
BY
JOHN T. HOMER 
Oklahoma City, Oklahoma 
1973
THE EFFECTS OF ADRENERGIC AGENTS ON THE 
HUMORAL IMMUNE RESPONSE
APPROVED BY'
DISSERTATION COMMITTEE
ACKNOWLEDGMENTS
I wish to thank Dr. William A. Cain for his advice, guidance 
and support throughout the course of this study.
Appreciation is also expressed to other members of the Depart­
ment of Microbiology and Immunology and the Department of Parasitology 
and Laboratory Practice for their interest and advice, and especially 
to Dr, Richard M. Hyde, Dr. Michael H. Ivey, Dr. Roderick E. McCallum, 
and Dr. Robert A. Patnode, who served as the reading committee for this 
dissertation.
Acknowledgment of financial assistance for this study is made 
to a Public Health Service, National Institute of Health, Training 
Grant. The timely assistance provided by Dr. Glenn S. Bulmer and 
Dr. Joseph J. Ferretti is acknowledged.
I wish to express my deepest appreciation to my wife, Deanna, 
and my children, John, James, and Lynne, for their assistance, encour­
agement, sacrifice and patience throughout my graduate studies.
Ill
TABLE OF CONTENTS
Page
LIST OF TABLES.............................................. ..
Chapter
I. INTRODUCTION AND LITERATURE REVIEW ....................... 1
II. MATERIALS AND METHODS....................................19
III. RESULTS................................................ 31
IV. DISCUSSION............................................ 61
V. SUMMARY................................................ 69
BIBLIOGRAPHY..................................................71
IV
LIST OF TABLES
Table Page
1. Effect of Propranolol on Homocytotropic Antibody
Formation in Rabbits............  33
2. Effect of Propranolol on Hemagglutinating Antibody
Production in the Rabbit............................... 34
3. Effect of Propranolol on Homocytotropic Antibody
Formation in the Rabbit, Qualitative Assay.............. 35
4. Titration of Homocytotropic Antibody by Passive
Cutaneous Anaphylaxis in Rabbits....................... 37
5. Effects of Propranolol and Complete Freund's Adjuvant
on Hemagglutinating Antibody Production in the Rabbit . . 38
6. Effects of Adrenergic Agents on Homocytotropic Antibody
Formation............................................ 40
7. Effects of Adrenergic Agents on Hemagglutinating
Antibody Formation.................................... 41
8. Effect of a Second Injection of Adrenergic Agent
and Antigen on Antibody Formation in the Rabbit........ 43
9. Effect of Varying the Dosage of Propranolol and
Phenoxybenzamine on the Immune Response in Rabbits. . . .  44
10. Effect of Varying the Dosage of Propranolol and
Phenoxybenzamine on Passive Cutaneous Anaphylaxis 
Antibody Formation in the Rabbit....................... 45
11. Effect of Varying the Dosage of Propranolol and
Phenoxybenzamine on the Formation of
Hemagglutinating Antibody in Rabbits....................47
12. Effects of Dibutyryl Cyclic-AMP and Adrenergic
Agents on Homocytotropic Antibody Formation
in the Rabbit........................................ 49
13. Effects of Dibutyryl Cyclic-AMP and Adrenergic Agents
on Hemagglutinating Antibody Formation in the Rabbit. . . 50
14. Titration of Egg Albumin, Bovine Serum Albumin and
Histamine by Direct Skin Test of a Sensitized Rabbit. . . 51
15. Effect of Propranolol on Skin Test Reactions in
Rabbits Immunized with Egg Albumin......................53
LIST OF TABLES— Continued 
Table Page
16. The Effects of Adrenergic Agents on the Development
of Blocking Antibody for the Immediate Skin Test
Reaction to Egg Albumin...............................55
17. Effect of Prior Intradermal Injection of Hyperimmune,
Passive Cutaneous Anaphylaxis Negative Serum on the
Skin Test Reaction in Sensitized Rabbits................ 56
18. Effects of Heat on Antibody Titer in Serum from
Rabbits Receiving Propranolol or Phenoxybenzamine
at the Time of Immunization........................... 58
19. Effect of Reduction and Alkylation on Antibody Titers
in Rabbits Receiving Adrenergic Agents at Time of 
Immunization.......................................... 39
20. Latent Period Required for Skin Fixation of
Homocytotropic Antibody in the Rabbit .................  60
VI
THE EFFECTS OF ADRENERGIC AGENTS ON THE HUMORAL IMMUNE RESPONSE
CHAPTER I 
INTRODUCTION .
Adenosine 3', 5’-phosphate (cyclic AMP) has been shown to 
occupy a central position in biological control as the intracellular 
mediator of a variety of hormones. It has been detected in almost 
all cells studied to date and is involved in a great number of cellu­
lar processes. Recently, an altered response in one of these hormone 
systems has been linked to a malfunction of the cyclic AMP mechanism. 
The cause of this malfunction is thought to be a reduced response by 
the enzyme adenyl cyclase to the catecholamines released by the auto­
nomic nervous system in reaction to stimuli. The result of this de­
creased adenyl cyclase activity is an unbalanced response by the auto­
nomic nervous system in which alpha receptor mediated responses are 
dominant.
Szentivanyi has proposed that this unbalanced response by 
the autonomic nervous system is the fundamental abnormality in atopic 
bronchial asthma and, in fact, all atopic allergies. Considerable 
clinical data, mostly on the physiological and metabolic responses of 
individuals with bronchial asthma, seem to support this theory. Ex­
perimentally, many of these same responses can be produced in normal
1
2individuals and animals by the use of agents which block adenyl cyclase.
A characteristic of the atopic allergies is the production 
of large amounts of reaginic antibody to a variety of substances which 
do not commonly immunize the general population. The role of the 
adenyl cyclase-cyclic AMP system in the immune response is as yet un­
known. Both adenyl cyclase (the beta receptor) and the as yet uniden­
tified alpha receptor are present in lymphoid cells. Experimental 
data suggest that these receptors may be important in both metabolic 
and functional processes of lymphoid tissues.
The purpose of this research was to examine the effects of 
agents involved in autonomic balance on immune responses in rabbits.
The effects on the humoral immune responses, especially homocytotropic 
antibody production, of various compounds which increase or decrease 
cyclic AMP levels were determined. In addition, compounds (phenoxy­
benzamine, norepinephrine) which block or stimulate the alpha receptor 
were studied for these same effects.
LITERATURE REVIEW
The cyclic nucleotide, adenosine 3', 5'-monophosphate (cyclic 
AMP) was discovered by Sutherland and his co-workers during their study 
of the factors controlling the breakdown of glycogen in liver cells 
(1, 2). Epinephrine was found to increase the breakdown of glycogen.
The action of epinephrine is mediated through its ability to activate 
a plasma membrane associated enzyme. This enzyme, later identified 
as adenyl cyclase (3), catalyzes the formation of cyclic AMP and in­
organic phosphate from adenosine triphosphate (ATP). Further studies
3showed this enzyme to be present in almost all animal cells, and to 
be activated by many hormones in addition to epinephrine (4).
As a result of their studies on the metabolic effects of the 
catecholamines in liver, muscle and adipose tissue, Robison et al. in 
1967 (5) proposed that adenyl cyclase was the beta-adrenergic receptor. 
The concept of specific receptors on the cell which react with drugs 
such as epinephrine was originally postulated by Langley (6). Ahlquist 
(7) proposed the dual adrenoreceptor hypothesis on the basis of differ­
ences in the potency of sympathomimetic amines in producing responses 
in a variety of tissues, both in vivo and in vitro. Alpha receptor 
responses were usually involved with excitatory functions (vasocon­
striction) and beta receptor responses with inhibitory functions (vaso­
dilation and inhibition of uterine or bronchial musculature). The 
stimulating effects of the catecholamines on the alpha receptor were 
blocked by ergotoxine, dibenamine and tolzaoline.
Support for this theory was provided by Powell and Slater (8) 
who demonstrated that dichloroiso-prenaline (DCI) selectively blocked 
some inhibitory effects of epinephrine and isoproterenol on isolated 
guinea pig trachea. Similar observations for DCI were made by Moran 
and Perkins (9) who found that DCI blocked the positive inotropic 
effects in the isolated rabbit heart of small doses of epinephrine, 
norephinephrine and isoproterenol.
The beta receptors have now been further differentiated into 
beta-1 and beta-2 receptors. Beta-1 receptors are involved in lipoly- 
sis and cardiac stimulation, while beta-2 receptors mediate broncho- 
dilation and vasodepression (10).
4The identity of the alpha receptor is still uncertain.
Belleau (11) has suggested that it may be part of a catecholamine 
catalyzed adenosine triphosphatase (ATPase) complex. This membrane 
bound complex may have as one of its functions the transport of cal­
cium into the cell.
Hadden et (12) have demonstrated that noradrenaline en­
hances the uptake of both glucose and potassium in lymphocytes. This 
action is associated with a direct action on membrane ATPase (13).
Alpha adrenergic stimulation, then, is not associated with 
increased production of cyclic AMP and in certain tissues appears to 
decrease cyclic AMP levels (14, 15). Hadden e^ (16) suggest that 
this may be an indirect result of norepinephrine stimulation of ATPase, 
thereby reducing the amount of ATP substrate available for adenyl cy­
clase.
A number of other hormones have also been shown to increase 
cyclic AMP levels, including glucagon, adrenocorticotropic hormone, 
luteinizing hormone, vasopressin, thyroxine and melanocyte-stimulating 
hormone. Functions mediated through cyclic AMP include insulin re­
lease, synthesis of glucocortico steroids, thyrosine release, calcium 
and phosphate mobilization and release, synthesis of progesterone, 
water and ion movement, tachycardia and melanophore dispersion (17- 
19).
Sutherland et al. (17) formulated the two messenger hypothesis 
of hormone action. The hormone, as the first messenger which circu­
lates in the blood, binds to the plasma membrane of the target cell 
and activates adenyl cyclase. Cyclic AMP, the second messenger, is
5then formed on the inner surface of the cell membrane, diffuses through 
the cell and causes the physiological response.
It is to be expected that any malfunction of the adenyl cyclase- 
cyclic AMP mechanism would be reflected in an altered response by the 
cells involved.
Szentivanyi (20) has proposed that such a malfunction of the 
beta receptor, adenyl cyclase, is the fundamental abnormality in asthma, 
resulting in an excessive irritability of the bronchial tree. Relative 
insensitivity of the beta adrenergic receptors (beta blockade) is pres­
ent in the bronchial glands, smooth muscle and mucosal blood vessels.
With a diminished responsiveness of the bronchodilating mechanism 
mediated through the beta receptors, the constricting mechanisms medi­
ated by the alpha receptors become dominant. This would account for 
the large variety of stimuli, both allergic and non-allergic, which 
can trigger bronchial constriction.
The beta-blockade theory offers an explanation for the many 
vagaries of atopy based on a single enzyme defect. In specific forms 
of atopy the receptor abnormality is postulated to involve the nasal 
mucosa, skin, antibody-forming cells and eosinophils, each independ­
ently and with varying degrees of severity. Considerable clinical 
experimental data supporting this theory have accumulated.
Middleton and Finke (21) report significantly less elevation 
of serum lactate, pyruvate and glucose levels in response to epineph­
rine injection in asthmatic patients than in normal subjects. Lockey 
et al. (22) noted that the intravenous infusion of epinephrine produced 
a smaller rise in blood glucose in asthmatic men. There was no
6difference in changes in free fatty acids and glycerol levels or re­
sponse to glucagon in normal and asthmatic individuals. Fireman et al. 
(23) found a diminished hyperglycemic response to epinephrine in asth­
matic children and in a group of children with eczema.
Altered responsiveness to histamine has also been reported 
in atopic patients. Cole and Roberts (24), using a skin window tech­
nique, found that atopic subjects responded to the intradermal injec­
tion of histamine with the exudation of large numbers of polymorpho­
nuclear leukocytes and with an eosinophilia of 3-15%. In non-atopic 
individuals, only an occasional cell was seen during the same period.
The wheeling response of atopic subjects was not different from that 
of the control group.
A few studies on cyclic AMP or adenyl cyclase levels in vari­
ous tissues and fluids from atopic individuals have been reported. 
Bernstein e^ al. (25) found no increase in urinary cyclic AMP excretion 
by asthmatic children in response to subcutaneous epinephrine. Epineph­
rine induced a twofold increase in urinary cyclic AMP excretion in 
normal control subjects. Falliers e^ al. (26), in their study of dis­
cordant allergic manifestations in monozygotic twins, report lower 
adenyl cyclase activity and higher ATPase activity in leukocytes from 
the twin with asthma than the twin without asthma. Adenyl cyclase was 
not stimulated by isoproterenol in the cells of the twin with asthma. 
Logsdon nt al. (27) also found that adenyl cyclase responsiveness to 
isoproterenol was absent in the leukocytes of asthmatics. Treatment 
with glucocorticosteroids restored adenyl cyclase responsiveness to 
isoproterenol.
7Experimental support for the beta adrenergic theory has been 
provided by the use of beta adrenergic blocking drugs in animals and 
human volunteers. Beta adrenergic blockade has been shown to enhance 
bronchial reactivity to inhaled allergens (28) and to methacholine (29) 
in patients with seasonal allergic rhinitis without a previous history 
of bronchial asthma. An acute airway obstruction which seemed to reach 
the intensity of that found in patients with bronchial asthma was pro­
duced by progressively increasing doses of propranolol. McNeill and
Ingram (30), using the whole body plethysmograph method, were able to
demonstrate a 50 to 100 percent increase in airway resistance in nor­
mal human subjects receiving propranolol. Similar findings have been 
noted by Besterman and Friedlander (31).
Fishel et (32) found that pretreatment with Bordetella
pertussis vaccine or dichloroisoproterenol significantly increased 
histamine and serotonin sensitivity in mice. Bordetella pertussis 
vaccine has been shown to have beta adrenergic blocking activity, as 
evidenced by its ability to lower adenyl cyclase activity and block 
responsiveness to epinephrine in mouse spleen cell suspensions (33).
The glycémie abnormality associated with asthma can be reproduced in 
vitro (34) or in vivo (35).
The vitro stimulation of leukocyte adenyl cyclase by adren­
ergic agents has been demonstrated with both broken cell (36) and in­
tact cell (37) preparations. These studies have been extended to in­
clude the effects of cAMP and adrenergic agents on the metabolism and 
mitosis of lymphoid cells. Smith ejt (38-39) observed that dibutyryl- 
cAMP, isoproterenol, and theophylline inhibited by 60% the uptake of
8tritiated thymidine by lymphocytes stimulated with phytohemagglutinin 
(PHA) when they were added during the first 24 hours of culture. No 
inhibition occurred when the agents were added after 24 hours of cul­
ture. Middleton and Hadden (40) found that this inhibition did not 
occur in the presence of propranolol.
Hadden e^ (41-45) studied the effects of timed pulses of 
various combinations of the catecholamines, cAMP, hydrocortisone, 
phentolamine and propranolol on tritiated thymidine uptake, glucose 
uptake, glycogen content, and lactate and production in phyto­
hemagglutinin-stimulated lymphocytes. Beta receptor stimulation by 
isoproterenol or high concentrations of cAMP inhibited thymidine up­
take when they were added to cultures at the onset of incubation. 
However, when it was added after 72 hours of culture, cyclic AMP 
stimulated DNA synthesis. This effect may be the result of the acti­
vation of glycogenolysis by cAMP, thereby impairing the accumulation 
of glycogen needed for DNA synthesis which normally reaches peak rates 
after 72 hours of culture. Beta receptor stimulation at this time 
would enhance glycogenolysis and, thus, DNA synthesis.
Alpha receptor stimulation by norepinephrine could be shown 
to augment the PHA-induced tritiated thymidine uptake at both the onset 
and the end of incubation (43). Glucose uptake and catabolism to lac­
tate were enhanced without a significant effect on glycogen content or 
^^C02 production. Enhanced DNA synthesis in response to alpha recep­
tor stimulation was observed only in the presence of hydrocortisone.
Norepinephrine was found to stimulate lymphocyte plasma mem­
brane ATPase activity through an alpha receptor mechanism (44). The
9relationship of alpha adrenergic modulation of ATPase activity to glu­
cose uptake is unknown at this time but may be explained by the cells' 
requirement to regenerate ATP. An alternate role could be the parti­
cipation of ATPase in the transport of glucose across cell membranes.
Epinephrine inhibits mitotic activity in short-term cultures 
of peripheral blood mononuclear leukocytes stimulated by phytohemag­
glutinin when it is added at the beginning of culture (46). No effect 
was noted when epinephrine was added for only the final 24 hours of 
culture. Cyclic AMP stimulates mitosis of thymocytes (47, 48).
The involvement of the autonomic nervous system in the immune 
response has been suggested by Kokas et (49). They noted that 
stimulation of the splanchnic nerve in the dog increased the phago­
cytosis-enhancing ability of its serum for Staphylococcus aureus and 
Bacillus typhosus (Salmonella typhosa). This effect could be abolished 
by ligation of the adrenal veins and increased by the injection of 
adrenalin. Desoxycorticosterone or an extract of adrenal cortex had 
no effect vitro. They concluded that the substances which produced 
the effect acted partly as opsonins and partly by direct stimulation 
of the leukocytes.
Draskoci and Jankovic (50) found that rats treated with reser- 
pine had impaired cellular and humoral immune responses to bovine serum 
albumin, as well as thymic atrophy. The mechanism of action of this 
drug has not been fully established, but it has been shown to lower 
serotonin and catecholamine levels in various tissue (51).
Epinephrine given subcutaneously with diphtheria toxoid was 
found to enhance antibody production twelvefold in the guinea pig (52).
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This adjuvant effect was postulated to be due to local vascular effects, 
since drugs which did not possess sympathomimetic activity had no adju­
vant action. No enhancement of the immune response to bovine gamma glob­
ulin was observed in rabbits when the antigen was given intravenously 
with epinephrine (53). The data suggest, instead, that antibody produc­
tion by the animals receiving epinephrine was suppressed,
Benner et_ al_. (54) found that epinephrine reduced antibody 
production to egg albumin tenfold in rats when it was given at a dos­
age of 600 micrograms/kilogram every six hours for either five days be­
fore or ten days after antigen injection. A decline in antibody produc­
tion to dinitropheny1-egg albumin has also been reported in mice treated 
with epinephrine after immunization (55), however the difference be­
tween experimental and control values was not statistically signifi­
cant. Epinephrine added to the culture fluid of spleen fragments of 
mice immunized with sheep red blood cells has been observed to suppress 
the number of plaque forming cells (56). The addition of epinephrine 
for a 24 hour period on day three, four or five of culture produced no 
reduction in plaque forming colonies (57).
Isoproterenol, another beta receptor stimulator, was found to 
suppress both total and homocytotropic antibody formation to dinitro- 
phenyl-egg albumin (55). Pearlman (58), however, reported an enhance­
ment of the vitro response by mouse spleen cells to sheep red blood 
cells when isoproterenol or aminophylline in concentrations of 10“  ^M 
to 10”  ^M was added to the cell cultures.
Ishizuka £t (59) found that cAMP and dibutyryl adenosine 
S', 5'-cyclic phosphate (dib-cAMP) enhanced antibody formation when
11
they were injected with sheep red blood cells or added vitro to a 
spleen cell suspension. The administration of cAMP 24 hours after anti­
gen produced even greater stimulation. Theophylline, a stabilizer of 
cAMP was found to enhance the stimulatory effects of poly A:U (60).
This effect was particularly pronounced with concentrations of poly 
A:U which are normally inactive. Theophylline alone did not alter the 
immune response.
Alpha receptor stimulation by norepinephrine at concentrations 
of 10"4 M to 10"7 M enhanced the vitro antibody response of mouse 
spleen cells to sheep red blood cells up to fivefold at the highest 
concentration (56). Makino and Reed (57) found, however, that nor­
epinephrine at a concentration of 9 x 10”  ^M inhibited the antibody 
response to sheep red blood cells.
Conflicting reports have also appeared regarding the effects 
of alpha adrenergic blockade. Pieroni and Levine (61) observed that 
dibenzyline, a haloalkylamine alpha adrenergic blocking agent, sup­
pressed the immune response of mice to tetanus toxoid injected with or 
without pertussis vaccine. Each mouse received one milligram of diben­
zyline. The weights of the mice were not given, but assuming an average 
weight of 25 grams, this would represent a dose of approximately 40 
mg/kg. Hadden (62) reported that doses of 0.2 to 0.5 mg/kg (the human 
therapeutic equivalent) had no effect on the cellular and humoral im­
mune response in the rabbit. Similar observations were made by Rosen­
blatt and Johnson (53) who used a dose of 3 mg/kg.
Beta adrenergic blockade has been reported to exert an adju­
vant effect on antibody production (54). Butoxamine and propranolol.
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at dosages of 15 mg/kg and 25 mg/kg, respectively, when administered 
every six hours for ten days beginning immediately after the injection 
of egg albumin, increase antibody production threefold. When the drugs 
were given at six hour intervals for five days before the antigen, 
butoxamine had little effect and propranolol decreased antibody produc­
tion tenfold.
In 1921, Prausnitz and Kustner (63) demonstrated in an aller­
gic individual a serum factor which caused a local sensitization of 
the wheal and erythema type in the skin of a normal human subject.
This factor was later detected by Coca and Grove (64) in the serum of 
subjects with hay-fever and asthma and was termed by them atopic rea- 
gin. These authors showed that the local passive sensitization lasted 
for four weeks or longer and that the skin-sensitizing capacity of 
reagin was diminished by heating the serum for one-half hour at 56° C.
During the next 40 years reaginic antibodies were studied by 
numerous investigators, however their exact nature remained unknown 
until the discovery of a new immunoglobulin class by Ishizaka et. al. 
(65) and Johansson and Bennich (66). This immunoglobulin class has 
been designated IgE (67).
IgE is a gamma globulin with a sedimentation coefficient of 
8.25 and a molecular weight of 200,000 (68, 69). The mean normal 
adult serum concentration is approximately 250 nanograms per milli­
liter. A special characteristic of this immunoglobulin is its ability 
to fix to the surfaces of tissue mast cells and circulating basophils. 
The union of antigen with specific cell-bound IgE antibody causes the 
cell to release histamine and other vasoactive materials responsible
13
for the edema and vasodilation associated with immediate type allergic 
reactions (70).
Increased amounts of IgE in the serum have been found in the 
atopic allergies, including asthma (71), eczema and seasonal rhinitis 
(72-73), allergic aspergillosis (74), food hypersensitivity and para­
site infections (75-77). High serum levels have also been reported in 
patients who have experienced anaphylactic reactions (78) as well as 
some non-atopic diseases including pulmonary hemosiderosis, severe 
liver disease (72) and IgE multiple myeloma (66).
While much of the data support the thesis that IgE is involved 
with allergic disease, some investigators have suggested that the im­
munoglobulin might also have a protective role. Callerame e^ (79), 
based on their study of bronchial biopsies from asthmatics, reported 
large numbers of IgE-containing cells in tissue showing inflammation, 
suggesting that this immunoglobulin plays a normal part in the inflam­
matory response. Ammann e^ (80) report data suggesting that a 
deficiency of IgE may be related to recurrent respiratory tract infec­
tion. The physicochemical properties of IgE and its role in the mech­
anisms of reaginic hypersensitivity have been reviewed by Ishizaka and 
Ishizaka (81), and Ishizaka (82), and more recently were the subject 
of a symposium (83).
Initially it was thought that antibodies capable of sensi­
tizing the skin of the homologous species for passive cutaneous ana­
phylaxis were rare in species other than man. They have now been 
found in almost all animals studied (84). These antibodies have now 
been designated as homocytotropic antibodies because of their ability
14
to fix to cells of animals of the same species in which they were 
formed or of closely related species (85).
The production of high levels of homocytotropic antibody in 
animals, except in the case of parasite infections (86) and a few cases 
of spontaneous allergy of the P-K type in dogs and cattle (87-88), 
normally requires the administration of antigen in combination with 
some form of adjuvant. A variety of substances have been used, in­
cluding incomplete and complete Freund's adjuvant (89), aluminum hy­
droxide (90), and a number of bacterial vaccines including Bacillus 
subtilis (91), Corynebacterium parvum (92), and Bordetella pertussis 
(93).
pertussis vaccine is of special interest because it appears 
to have pharmacological properties associated with beta adrenergic 
blocking agents (51, 94-101). Finger jet al. (102) present evidence 
suggesting that pertussis causes multiplication of antigen sensitive 
target cells or affects the initial stages of differentiation of these 
cells. A similar conclusion was reached by Reed et (55). The 
cellular immune response may be decreased by pertussis administra­
tion (103).
The wide use of the rabbit in immunological research and its 
reputation as a good antibody producer have prompted considerable 
study on homocytotropic antibody in this species.
The first report of an antibody capable of sensitizing rab­
bit skin for homologous passive cutaneous anaphylaxis (PCA) was that 
by Zvaifler and Becker (104). The antibody was produced by immuniza­
tion with bovine gamma globulin coupled with dinitrophenyl sulfonic
15
acid sodium salt in Freund's complete adjuvant. Activity was detected 
as early as the sixth or seventh day following immunization and was 
gone by the third week. The antibody was heat- and mercaptoethanol- 
labile, non-precipitating, non-complement fixing, required a three day 
latent period for skin fixation to demonstrate PCA activity, had an 
electrophoretic mobility faster than rabbit IgG globulin and was eluted 
from Sephadex G-20Û between IgM and IgG.
A rabbit antibody with skin-sensitizing activity was also 
reported by Onoue e^ (105). They concluded that rabbit PCA activ­
ity was found in the 7S IgA globulin fraction.
Zvaifler elt al. (106) observed that rabbits infected with 
Schistosoma mansoni produced a heat- and mercaptoethanol-labile PCA 
antibody seven to twelve weeks after infection. Antibody titers re­
mained elevated for three to six weeks, then declined to low levels 
or disappeared completely. Reinfection at 36 weeks caused a return 
of the antibody in half of the animals.
Lindqvist (107) reported the presence of a heat stable, mer- 
captoethanol sensitive PCA antibody with an estimated molecular weight 
of 200,000 in rabbits immunized with tetanus toxoid. The antibody 
was detectable in serum over a period of 6 to 133 days after a primary 
immunization. Its appearance was not affected by changes in the route 
of immunization, treatment with 6-mercaptopurine or splenectomy (108).
Revoltella and Ovary (109) reported that the use of aluminum 
hydroxide as an adjuvant resulted in the formation of homocytotropic 
antibody in all of their rabbits, in contrast to the variable results 
obtained with complete Freund's adjuvant. With small amounts of
16
antigen it was possible to obtain homocytotropic antibody in only three 
out of ten animals. Similar findings were noted by Freeman et (90). 
Kindt and Todd (110) could find no significant difference between homo­
cytotropic antibodies produced in the primary and the secondary immune 
response.
Heat-sensitive and heat-resistant homocytotropic antibodies 
have been found in the same serum from rabbits immunized with soluble 
crude Ascaris extracts, or with extracts absorbed onto aluminum hydro­
xide (111). Both antibodies were inactivated by reduction and alkyla­
tion.
Oral administration of egg albumin or bovine serum albumin 
resulted in the production of homocytotropic antibody by a small num­
ber of rabbits (112). Serum titers of anti-bovine serum albumin homo­
cytotropic antibody persisted for several months following the ces­
sation of antigen administration.
An enhancement of homocytotropic antibody formation by the 
administration of 19S antibodies one day before or after antigenic 
stimulation was reported by Strannegard and Belin (113). The admin­
istration of 75 antibody prior to immunization, or together with the 
antigen, resulted in the inhibition of homocytotropic antibody forma­
tion (114-115).
Pinckard £t (116) found that neonatal rabbits immunized 
with alum-precipitated or soluble bovine serum albumin (BSA) in con­
junction with Corynebacterium parvum adjuvant produced only homocyto­
tropic antibody during the neonatal period and throughout adult life. 
When they were immunized at seven days of age with soluble BSA, the
17
animals became immunologically unresponsive to BSA, with the excep­
tion of anti-BSA homocytotropic antibody produced when they were adults. 
Immunization on day seven with BSA and iC. parvum resulted in the produc­
tion of anti-BSA antibody detectable by all the test procedures.
Henson and Cochrane (89) showed that rabbits immunized with 
BSA and complete Freund's adjuvant produced both heat labile and com­
plement-, platelet- and neutrophile-dependent homocytotropic antibodies. 
The complement-dependent antibody persisted in the circulation for long 
periods of time and had physicochemical characteristics suggesting a 
rabbit IgG antibody.
Characterization of the physicochemical and biological proper­
ties of homocytotropic antibody against dinitropheny1-bovine gamma glob­
ulin and egg albumin has been performed by two groups of investigators 
(117-118). Neither group was able to demonstrate a complement-depend­
ent, heat stable homocytotropic antibody. The homocytotropic antibody 
found in both studies was a beta globulin with a sedimentation coef­
ficient of approximately 8.5S which eluted from a Sephadex G-200 col­
umn earlier than IgG. The molecular weight was estimated to be approx­
imately 200,000. The antibodies were heat labile and required a skin 
fixation period of 72 hours. The ability of the antibody to sensitize 
skin for the homologous PCA reaction was not blocked by absorption 
with antisera specific for rabbit immunoglobulins G, A or M.
Because the unique physicochemical properties and biologic 
function of this immunoglobulin are so similar to human IgE, Ishizaka 
et al. (118) have tentatively designated it rabbit IgE. The demonstra­
ted ability of the rabbit to produce a homocytotropic antibody similar
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to human immunoglobulin E makes it an ideal model for studying the 
effects of adrenergic agents on the immune response.
The purpose of this research was to examine the effects of 
agents involved in autonomic balance on the humoral immune responses, 
especially homocytotropic antibody production. Various compounds 
which increase or decrease cyclic AMP levels and compounds (phenoxy- 
benzamine, norepinephrine) which block or stimulate the alpha recep­
tor were studied for these same effects.
CHAPTER II 
MATERIALS AND METHODS
Experimental Animals 
Rabbits of both sexes and of mixed breeds, weighing approx­
imately 1.2 - 3.4 kg, were used in these experiments. All of the ani­
mals were obtained from local sources and fed a commercial rabbit chow 
and water ad libium. The animals were housed in individual cages or 
in groups of five in large hutches. All animals were observed for at 
least 72 hours before being used for experimental purposes.
Preparation of Antigen and Adrenergic Agents 
The following agents were dissolved in pyrogen-free 0.85%
NaCl (McGraw Laboratories, Glendale, California) in the indicated con­
centrations: egg albumin (5x crystallized, B-grade, Calbiochem, San
Diego, California), 0.0001, 0.001, 0.01, 1.0, 10, 20, 100, and 200 mg/ 
ml; bovine serum albumin (Armour Pharmaceutical Company, Kankakee, 
Illinois) in concentrations of 0.0001, 0.001, 0.01, 0.1, 1, 10, 20 
and 100 mg/ml; norepinephrine (Arterenol, Sigma Chemical Company, St. 
Louis, Missouri), 600 micrograms/ml; propranolol (furnished through 
the courtesy of Dr. R. 0. Davies, Ayerst Laboratories, New York, N. Y.) 
2, 20, and 200 mg per ml; Sotalol (furnished through the courtesy of 
Dr. G. R. McKinney, Mead Johnson & Company, Evansville, Indiana), 200
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mg per ml; DL-isoproterenol (Sigma Chemical Company, St. Louis, Mis­
souri), 250 micrograms per ml. Phenoxybenzamine (Dibenzyline, fur­
nished through the courtesy of Dr. G. J. Oswald, Smith, Kline, and 
French Laboratories, Philadelphia, Pennsylvania) was dissolved in ab­
solute ethyl alcohol (reagent grade, U. S. Industrial Chemical Company, 
New York, N. Y.) in concentrations of 4, 40, 200, and 400 mg per ml.
Dibutyryl cyclic AMP (N^O^-dibutyryladenosine 3'-5' cyclic 
phosphate, Na, 8-hydrate, A-grade, Calbiochem, San Diego, California) 
was dissolved in cold pyrogen free 0.85% NaCl in a concentration of 
20 mg/ml immediately prior to use and stored in ice during the immu­
nization procedure.
Initial Studies
Rabbits were injected with propranolol, 10 mg/kg intravenously 
(I.V.) or 10, 15, 20, 25 and 30 mg/kg subcutaneously, to determine the 
maximum tolerated dosage for this drug.
Immunization of the Animals
Animals were immunized by intrafootpad injections of egg 
albumin, 25 mg per kg, either alone or mixed with one of the follow­
ing agents: propranolol, 0.2, 2.0, and 20 mg per kg; Sotalol, 20 mg
per kg; isoproterenol, 50 micrograms per kg; norepinephrine, 120 micro­
grams per kg; phenoxybenzamine, 0.4, 4.0, 20, and 40 mg per kg. The 
mixtures were made up to a volume of 1 ml by the addition of 0.85%
NaCl. Each footpad was injected with 0.25 ml of the mixture. Cer­
tain animals received a secondary injection of antigen. This was 
given either as 4 mg per kg in 1 ml of 0.85% NaCl, 0.25 ml per footpad.
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or as a single injection of 10 mg per kg in 1 ml of 0.85% NaCl intra­
muscularly in a hind leg. For some animals, this mixture also con­
tained 20 mg per kg of propranolol, 75 micrograms/kg of isoproterenol, 
or 1 ml of absolute ethyl alcohol. In other animals the propranolol 
and isoproterenol were given in a separate 1 ml injection intramuscu­
larly in the opposite leg.
Additional rabbits were injected with egg albumin, 25 mg/kg 
in 0.5 ml of 0.85% NaCl and 0.5 ml of Freund’s complete adjuvant (Dif- 
co Laboratories, Detroit, Michigan). The egg albumin and the adjuvant 
were emulsified by homogenizing for 4 minutes on a Sorval Omnimixer 
(Ivan Sorvall, Inc., Norwalk, Connecticut).
In one experiment, dibutyryl cyclic AMP, 44 mg per kg in 4 
ml of cold 0.85% NaCl, was injected into the footpads, 1 ml per foot­
pad. Thirty minutes later, footpad injections of egg albumin, 25 
mg/kg, alone, and mixed with 20 mg per kg of propranolol or 0.4 mg 
per kg of phenoxybenzamine were administered. In all cases, the 
second injection consisted of one ml total volume, 0.25 ml per foot­
pad.
Collection and Storage of Serum 
Prior to immunization, and at intervals thereafter, all ani­
mals were bled by cardiac puncture or from the central artery of the 
ear. The blood was allowed to clot at room temperature and was placed 
in a refrigerator at 4° C overnight. The clot was then discarded and 
the serum centrifuged at 1000 G (3000 RPM) for five minutes. One to 
five ml samples of the cell-free serum were placed in screw cap vials 
and stored without chemical preservatives at -20° C. Samples were
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thawed as needed immediately before use and were then refrozen. In 
some instances the samples were kept for several days at 4° C after 
thawing.
Passive Cutaneous Anaphylaxis (PCA)
Homocytotropic antibody titers were determined by a slight 
modification of the method of Zvaifler and Becker (80). These assays 
were performed as follows:
Serum from immunized rabbits was diluted with pyrogen-free 
0.85% NaCl to obtain serum concentrations of undiluted, 1/4, 1/16, 
1/64, 1/128, 1/256, and in some cases 1/512 and 1/1024. For conven­
ience, these concentrations will be referred to as their -logg equi­
valents (0, 2, 4, 6, 7, 8, 9 and 10, respectively).
The backs of nonimmunized recipient rabbits were shaved with 
an electric clipper (John Oster Manufacturing Company, Milwaukee, 
Wisconsin). The shaved area was then marked with a water proof mark­
ing pen into four rows of squares, each row containing 7 squares 
approxmiately 40 x 40 mm each. Eighteen to 42 hours later, 0.15 ml 
of serum was injected intradermally into the center of each square 
with a 26 gauge needle and disposable tuberculin syringe (Becton, 
Dickinson and Company, Rutherford, New Jersey). A single syringe and 
needle were used for all the dilutions of a single serum. The most 
dilute sample was injected first and the undiluted serum last. Suf­
ficient material was drawn into the syringe each time to allow the 
injection of two animals. An injection of 0.15 ml of the pyrogen- 
free, 0.85% NaCl used for serum dilutions was made into the skin of 
the nuchal region at the time of the serum injections as a negative
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control.
Sixty-eight to 72 hours after the serum injections, 0.1 ml 
(0.55 mg) of histamine dihydrochloride (B grade, Calbiochem, Los Angel­
es, Calif.) was injected intradermally into a previously uninjected 
site on the back as a positive control. The animal then received 2.0 
ml of egg albumin, 10 mg per ml, and 2.0 ml of 0.5% Evan's Blue dye 
(Warner-Lambert Company, Morris Plains, New Jersey) via the margional 
ear vein. After at least one hour, the animal was killed by cervical 
dislocation and skinned. With the aid of a light box, the underside 
of the skin was examined for areas of bluing. Measurements of the 
diameter of each area were made in two directions and recorded in 
millimeters. In some cases the area of bluing was recorded only as 
"slight."
All of the serum samples from a single experimental group 
were placed on the same recipient animal and each sample was tested 
in the skin of two animals.
Latent Period Required for Skin Fixation of Antibody
Rabbits were injected with serum as described under PCA, 
then challenged with egg albumin and Evan's Blue dye at 24, 48, or 
72 hr.
Passive Hemagglutination (PHA)
A modification of the procedure of Johnson e^ al. (119) was 
used to couple egg albumin to rabbit red blood cells. Reagent grade 
chemicals (Fisher Scientific Company, Fairlawn. New Jersey) were used 
to prepare all solutions. A modified Alsevers solution was prepared
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as follows: To a 1000 ml volumetric flask were added 20.5 gm D-
glucose, 20.0 gm disodium ethylenediamine tetraacetate, 4.1 gm of 
NaCl, and 10 ml of normal rabbit serum. The contents were brought to 
volume with distilled water and the pH was adjusted to 7.0 using IN 
NaOH or 1 N HCl.
A phosphate-buffered saline (PBS) solution, pH 7.2, was pre­
pared by the addition of 24 ml of 0.15 M KH^PO^ and 76 ml of 0.15 M 
Na^ HPOy^  to 100 ml of 0.85% NaCl.
Normal rabbit blood was collected from the central artery of 
the ear into a syringe containing an equal volume of modified Alsevers 
solution. After mixing by slowly rotating the syringe, the blood was 
expressed into a conical tube and centrifuged for 5 minutes at 1000 G 
(3000 RPM) in an International model HN-S centrifuge equipped with a 
No. 215 horizontal head (International Equipment Company, Needham 
Heights, Mass.). The plasma and buffy layer were then removed by 
aspiration and discarded. Ten ml of modified Alsevers solution were 
added to the tube and suspension of the erythrocytes was accomplished 
by touching the tube to a vortex mixer (Scientific Industries Incor­
porated, Springfield, Massachusetts).
The erythrocytes were then packed again at 1000 G for 5 
minutes. This washing procedure was repeated three times. After 
the last wash a volume of PBS equal to the packed cell volume was 
added to make a 50% (V/V) cell suspension.
To prepare 50 ml of a 0.5% suspension of egg albumin coupled 
red blood cells, 2.5 ml of 1-ethyl-3-(3-dimethylaminopropropyl) 
carbodiimide HCl, 100 mg/ml, (Ott Chemical Company, Muskegon, Michigan)
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was added to 15 ml of egg albumin (10 mg/ml) in PBS and 0.5 ml of the 
50% suspension of rabbit red blood cells. The mixture was allowed to 
stand for 60 minutes at room temperature with intermittent shaking.
The cells were then washed once in PBS and 3 times in modified Alsev­
ers solution. After the last wash, the cells were suspended to a 
volume of 50 ml. Sensitized cells remained stable for at least 7 days 
at 4° C if they were washed 3 times with modified Alsevers solution 
just before use.
Titration of antibody was performed by the microtiter method. 
A 0.025 ml volume of modified Alsevers buffer was added to each well 
of a V-bottom, disposable plastic tray (Linbro Chemical Co. Inc., New 
Haven, Conn.) by means of a calibrated pipette dropper attached by 
plastic tubing to a serum bottle. A pipetting device, equipped with 
a disposable polyethylene tip (Carworth Division, Becton, Dickinson,
New York, New York) was used to deliver 0.025 ml of serum into the
12first well in each row. Sera were diluted serially to either 1:2 
or 1:2^^ with a multi-microdiluter equipped with micro diluters of 
0.025 ml capacity (Cooke Engineering Company, Alexandria, Virginia).
A 0.025 ml volume of sensitized red cells (0.05%) was then added to 
each well. Each sample was titrated in duplicate and each plate also 
contained a saline control and a normal serum control. The plates 
were incubated overnight at 4° C. The greatest serum dilution in 
which the red cells did not form a compact button on the bottom of 
the well was recorded as the end point. When duplicate samples gave 
different end points, the average of the two values was recorded.
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Mercaptoethanol Sensitivity of Homocytotropic and 
Agglutinating Antibodies
The effects of reduction with 2-mercaptoethanol followed by 
alkylation with iodoacetamide on homocytotropic and agglutinating anti­
body titers were examined. Rabbits were immunized with egg albumin,
25 mg/kg, and propranolol, 20 mg/kg, or phenoxybenzamine, 0.4 mg/kg, 
by intrafootpad injections. Sera from both early (7 day) and late 
(49 day) bleedings were tested.
The technique described by Zvaifler and Becker (80) was used. 
One ml samples of serum were placed in dialysis tubing (Fisher Scien­
tific) and dialyzed against 500 ml of 0.1 M 2-mercaptoethanol for 3 
hr at room temperature. They were then dialyzed against 0.02 M iodo­
acetamide (Calbiochem) for 4 hr at room temperature, followed by sev­
eral changes of phosphate-buffered saline (PBS) for 18-24 hr at 4° C. 
The PBS was prepared as follows, using reagent grade Fisher chemicals:
1 L of distilled water was added to 6.8 gm of NaCl, 1.483 gm of 
Na2HP0^ • 7 H^O, and 0.433 gm of KHgPO^ • H2 O. The pH was adjusted 
to 7.2 using IN HCl or IN NaOH. Control samples of serum were dia­
lyzed against PBS instead of 2-mercaptoethanol, then treated with 
iodoacetamide and dialyzed against PBS in a manner identical to that 
used with the test samples. Sera were tested for PCA and PHA activ­
ity as described above.
Heat Stability of Homocytotropic and Agglutinating Antibodies
A two ml volume of whole serum was placed in a constant temp­
erature water bath at 56° C. Samples were removed at 1, 2, 3, and 4 
hrs and tested for PCA and PHA activity. The interval between
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completion of heating and injection for the PCA reaction did not ex­
ceed 2 hr, however samples were stored overnight at 4° C before the 
PHA tests were performed. Sera from both early (7 day) and late (49 
day) bleedings were examined for heat stability. The sera were from 
rabbits immunized with egg albumin, 25 mg/kg, and propranolol, 20 
mg/kg or phenoxybenzamine, 0.4 mg/kg, by intrafootpad injections.
Titration of Skin Test Materials
The optimum concentrations of egg albumin, bovine serum al­
bumin, and histamine for the direct skin test were determined. A rab­
bit producing homocytotropic antibody was shaved and injection sites 
were marked as described above. Dilutions of the antigen, egg albu­
min, and bovine serum albumin for specificity control, were made in 
0.85% NaCl. The following concentrations were injected intradermally 
in a 0.10 ml volume: 10,000, 1,000, 100, 10, 1, 0.1, and 0.01 micro­
gram. Histamine in 0.85% NaCl, containing 5,500, 550, 55, 5.5, 0.55, 
0.055, and 0.0055 micrograms/0.10 ml, was also injected intradermally.
After completion of the intradermal injections, 2.0 ml of 
0.5% Evans Blue dye was given intravenously. One hour later the areas 
of bluing were measured and recorded as described previously.
Effects of Propranolol on the Direct Skin 
Test and the Reaction to Histamine
A group of rabbits immunized three weeks previously with egg 
albumin, 25 mg/kg, and propranolol, 0.2, 2.0, and 20 mg/kg, were exam­
ined, by direct skin test, for their response to egg albumin, bovine 
serum albumin, histamine, and saline, before and after the injection 
of propranolol, 20 mg/kg. The concentrations of the test substances
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were: (1) Egg albumin - 10 micrograms/0.1 ml, (2) Bovine serum albu­
min - 10 micrograms/0.1 ml, (3) Histamine - 0.55 micrograms/0.1 ml, 
and (4) Saline (0.85% NaCl). All dilutions were made in 0.85% NaCl. 
Each animal received 2.0 ml of 0.5% Evan's Blue dye prior to intra­
dermal injection of the test materials. Forty-five to sixty minutes 
after application of the test materials the areas of bluing were ob­
served through the skin and recorded as described above. Each animal 
then received 20 mg/kg of propranolol in a 1.0 ml volume of 0.85%
NaCl, 0.25 ml being injected into each footpad. A second series of 
intradermal injections of the test materials were made 1/2 hour after 
the propranolol injection. Forty-five to sixty minutes after this 
series of injections the areas of bluing were recorded as described 
above.
Tests for Blocking Antibody
These procedures were developed to test the possibility some 
class of antibody might block immediate hypersensitivity by occupying 
tissue sites competitively. Sera, without homocytotropic antibody 
for egg albumin detectable by PCA, were tested for their ability to 
block the immediate skin reaction to egg albumin.
Serum samples, to be tested by this procedure, were selected 
from animals which had been immunized with egg albumin, 25 mg/kg, 
alone or in combination with one of the following drugs: (1) Sotalol,
20 mg/kg, (2) Norepinephrine, 120 micrograms/kg, (3) Isoproterenol,
50 micrograms/kg. Samples obtained from early (day 7), middle (day 
28 and late (day 49) bleedings were assayed. Preimmunization samples 
were included as controls.
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A sensitized rabbit, which had been immunized three weeks 
previously with egg albumin, 25 mg/kg, and propranolol, 20 mg/kg, by 
footpad injection, was prepared as described prevously for the PCA 
test. Serum samples, either undiluted or diluted 1:5 with pyrogen- 
free 0.85% NaCl were injected in 0.15 ml volumes into separate sites. 
Approximately 30 minutes after the serum injections, 2.0 ml of 0.5% 
Evan's Blue dye was injected I.V. Each site was then injected with 
0.1 ml of egg albumin in 0.85% NaCl, 10 micrograms per 0.1 ml. One 
hour later the rabbit was killed and skinned and the areas of bluing 
on the underside of the skin were measured and recorded as described 
previously.
In a second experiment, a sensitized rabbit was injected 
intradermally with 0.15 ml volumes of sera from a rabbit immunized 
with egg albumin, 25 mg/kg, and isoproterenol, 50 micrograms/kg, by 
footpad injections. These sera were negative for homocytotropic anti­
body, as measured by the PCA test. The prepared skin sites, and nor­
mal skin sites, were challenged at 1/2, 6, 24 and 41 hours with a 
0.1 ml (10 microgram) intradermal injection of egg albumin. Two ml 
of 0.5% Evan's Blue dye were injected intravenously prior to the 1/2 
and 22 hr challenges. The areas of bluing were measured through the 
skin and recorded as described previously.
In Vitro Binding of Egg Albumin
Sera from rabbits immunized with egg albumin, 25 mg/kg, alone 
or with isoproterenol, 50 micrograms/kg, by footpad injection, were 
tested for their ability to bind egg albumin dg. vitro. The sera were 
PCA negative and had PHA titers of 11 and 12 respectively. A 2 ml
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volume of serum, either undiluted or diluted 1:10 with 0.85% NaCl, 
was mixed with an equal volume of egg albumin, 200 micrograms/ml, and 
allowed to stand at 4° C for 4 or 24 hours.
The back of a rabbit sensitized to egg albumin by the footpad 
injection of egg albumin 25 mg/kg and propranol 20 mg/kg, was shaved 
and 0.1 ml volumes of the serum-egg albumin mixtures, egg albumin, 
saline, and serum were injected into the skin. Evan’s Blue dye, 0.5%, 
2 ml was injected intravenously at the same time. The reactions were 
read on the outside of the skin and recorded as described previously.
CHAPTER III 
RESULTS
Initial Studies 
Initial studies were directed to the determination of the 
maximum dosage of propranolol tolerated by the rabbit and the best 
route for administering it. Two animals were injected with 10 mg/kg 
of propranolol, one intravenously and one subcutaneously. The rabbit 
receiving the intravenous injection died immediately while the other 
animal was not visibly affected. Additional rabbits were injected 
subcutaneously with 15, 20, 25, or 30 mg/kg of propranolol. Within 
15 minutes after the injection, rabbits receiving 25 or 30 mg/kg be­
came prostrate, with head drawn back and the legs rigidly extended. 
Approximately 45 minutes later both animals were able to stand upright 
and they appeared normal. As the result of this study, 20 mg/kg was 
selected as the maximum dosage of propranolol.
Two rabbits were immunized with a mixture of propranolol 
20 mg/kg and egg albumin 25 mg/kg in the footpads. Because of tech­
nical difficulties one of the animals received only one-fourth the 
intended dosage. A third rabbit was injected with egg albumin, 25 
mg/kg, and Freund's complete adjuvant in the footpads. The fourth 
rabbit received egg albumin, 25 mg/kg, and 0.85% NaCl in the footpads.
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Homocytotropic antibody, as demonstrated by the homologous 
passive cutaneous anaphylaxis (PCA) reaction, was produced only by 
the rabbits receiving propranolol (Table 1). Both animals had logg 
titers of 8 on the twelfth day after immunization and titers of 4 on 
the thirtieth day after immunization. No attempt was made to measure 
the diameters of the areas of bluing in this initial experiment be­
cause of the large amount of fur on the skin of the test animals.
In subsequent experiments more attention was given to shaving the 
skin clean before the serum injections were made.
All four of the animals produced antibodies which aggluti­
nated red blood cells sensitized with egg albumin (Table 2). However 
the rabbits receiving egg albumin with either Freund's complete adju­
vant or propranolol had higher antibody titers. The animal which re­
ceived antigen in saline made only a minimal response.
In the next experiment, animals were immunized in the foot­
pads with egg albumin, 25 mg/kg, in saline, Freund's complete adju­
vant, or 20 mg/kg of propranolol. The saline and Freund's complete 
adjuvant groups consisted of two animals each, and the propranolol 
group, three animals. The animals were bled at two to three day in­
tervals beginning on the eighth day after immunization. Antibody 
activity was detected by a qualitative PCA procedure using undiluted 
serum. Results are shown in Table 3. PCA antibody could be demon­
strated consistently only in the serum of the animals receiving pro­
pranolol or Freund's complete adjuvant. One animal which received 
egg albumin in saline had PCA activity on day 8 only, while the other 
animal in this group showed activity from day 18 to the end of the
TABLE 1
EFFECT OF PROPRANOLOL ON HOMOCYTOTROPIC ANTIBODY FORMATION IN RABBITS
Logg PCA Antibody Titer^ 
Days Post-Immunization
Animal Number Mixture Injected 0 12 15 18 21 30
1 Propranolol, 5 mg/kg 
Egg Albumin, 6.2 mg/kg
-1 8 5 7 5 4
2 Propranolol, 20 mg/kg 
Egg Albumin, 25 mg/kg
-1 8 7 6 6 4
3 Freund's Complete Adjuvant 
Egg Albumin, 25 mg/kg
-1 -1 -1 —1 —1 -1
4 Saline, Egg Albumin, 25 
mg/kg
-1 -1 -1 -1 -1 -1
^ Logg Antibody Titer = -Log of highest serum dilution showing evidence of antibody 
activity. For convenience, sera without detectable activity were assigned a titer of -1.
TABLE 2
EFFECT OF PROPRANOLOL ON HEMAGGLUTINATING ANTIBODY PRODUCTION IN THE RABBIT
Log^ Antibody Titer^ 
Days Post-Immunization
Animal Number Mixture Injected 0 12 15 18 21 30
1 Propranolol, 
Egg Albumin,
5 mg/kg 
6.2 mg/kg
-1 9 7.5 7 8 7.5
2 Propranolol, 
Egg Albumin,
20 mg/kg 
25 mg/kg
-1 10.5 10 10 9.5 10
3 Complete Freund*s Adjuvant 
Egg Albumin, 25 mg/kg
-1 9 10 11 12 12
4 Egg Albumin, 25 mg/kg -1 2 1 1.5 2 1
U3
Log2  Antibody Titer = -Log^ of highest serum dilution showing evidence of antibody 
activity. For convenience, sera without detectable activity were assigned a titer of -1.
TABLE 3
EFFECT OF PROPRANOLOL ON HOMOCYTOTROPIC ANTIBODY FORMATION 
IN THE RABBIT, QUALITATIVE ASSAY
PCA, Undiluted Serum^
Days, Post-Immunization
Animal Number Adj uvant 0 8 10 12 15 18 21 31
1 Freund's Complete 
Ad j uvant
0 + + + + + + +
3 It 0 + + + + + + +
4 Propranolol, 20 
mg/kg
0 + + + + + + +
5 II 0 + + + + + + +
6
II 0 + + + + + + +
7 None 0 0 0 0 0 + + +
8 0 + 0 0 0 0 0 0
(jO
Ul
0 = no reaction, + = positive reaction
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experiment. Sera from all of the animals appeared to be negative for 
PCA antibody when an attempt was made to titrate their activity. The 
procedure was repeated and quantitative PCA titers were determined 
using a new group of recipient animals (Table 4). Titers of from 3 
to 6 were seen in the propranolol treated animals. No PCA activity 
was detected in the serum from one animal receiving complete Freund's 
adjuvant, and a titer of 4 was observed in the other. Only one of 
the animals which received egg albumin alone had detectable PCA anti­
body and this was on days 31 and 35. No explanation can be given for 
the failure of the first group of test animals to become passively 
sensitized, or for the apparent loss of activity in some serum samples. 
All of the animals produced hemagglutinating antibodies, with the 
highest titers in those which had received Freund's complete adjuvant 
(Table 5). The maximum logg titers were 24 in this group, approxi­
mately twice those of the propranolol-treated group, and three to 
four times those of the group receiving egg albumin alone.
Studies on the Effects of Other Adrenergic 
Agents on Antibody Formation
Studies were then initiated to examine the effects of other 
adrenergic agents, including a second beta blocking agent, Sotalol; 
an alpha blocking agent, phenoxybenzamine; a beta stimulator, iso­
proterenol; and an alpha stimulator, norepinephrine. The drug dos­
ages used were those reported in the literature as the maximum toler­
ated dosage or a dosage which produced a physiological response. All 
the animals received the adrenergic agent mixed with 25 mg/kg of egg 
albumin via injection of the footpads. The results of this study are
TABLE 4
TITRATION OF HOMOCYTOTROPIC ANTIBODY BY PASSIVE CUTANEOUS ANAPHYLAXIS IN RABBITS
Animal
Log2  Antibody Titer^ 
Days Post—Immunization
Number Adj uvant 0 8 10 12 15 18 21 31 35
1 Freund's Complete 
Adjuvant
-1 -1 -1 —1 —1 —1 -1 -1 -1
3 II -I 4 4 4 4 4 4
4 Propranolol, 20 
mg/kg
-1 6 6 5 3 4
5 If -1 6 5 -1 3 5 4
6 II -1 -1 -1 -1 4 -1 -1
7 None -1 -1 -1 4 4
8 II -1 -1 "1
U)
Log Antibody Titer = -Logg of the highest serum dilution showing evidence of antibody 
activity. For convenience, sera without detectable activity were assigned a titer of -1.
TABLE 5
EFFECTS OF PROPRANOLOL AND CCMPLETE FREUND'S ADJUVANT ON HEMAGGLUTINATING
ANTIBODY PRODUCTION IN THE RABBIT
Animal
PHA Log2  Titer 
Days Post-Immunization
Number Adjuvant 0 8 10 12 15 18 21 31 35
1 Freund's Complete 
Adj uvant
-1 12 12 12 13 20.5 22 20 21.5
3 II -1 -1 12.5 13 14 16 24 24 23
4 Propranolol, 20 
mg/kg
-1 6 8 7 10 12 12 11.5 12
5 II -1 8 9.5 9 9 11 16.5 12 12
6 11 -1 5 5 5 7 7.5 8.5 12 12
7 None -1 ' 5.5 5 6 5 5.5 6 8.5 5
8 II -1 3.5 5.5 6 6.5 7.5 6.5 2 5.5
w
00
Logg Antibody Titer = -Log^ of the highest serum dilution showing evidence of antibody 
activity. For convenience, sera without detectable activity were assigned a titer of -1.
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summarized in Tables 6 and 7. Homocytotropic antibody was produced by 
all propranolol-treated animals and by four of the five animals re­
ceiving phenoxybenzamine. Antibody was detected in both groups on day 
7, but the phenoxybenzamine-treated group as a whole responded more 
slowly than the propranolol-treated group. All of the propranolol- 
treated animals were producing antibody by day 14, while 4 of 5 phenoxy­
benzamine-treated animals had responded by day 28.
To test the effect of these drugs on the induction of immuno­
logical memory, a second injection of egg albumin, 4 mg/kg, was made 
into the footpads of each animal on day 28. Homocytotropic antibody 
activity was detected in a single norepinephrine-treated animal begin­
ning on day 35. Increases in titer were noted in both the propranolol- 
and phenoxybenzamine-treated groups three weeks after the second anti­
gen injection. Homocytotropic antibody was detected in a single 
Sotalol-treated animal on day 42 only. None of the isoproterenol- 
treated animals nor the control animals produced homocytotropic anti­
body (Table 7). Titers were approximately the same in all groups on 
day 7, and declined more slowly in the propranolol and phenoxybenza­
mine groups. Titers increased to approximately the same levels after 
the secondary immunization.
Selected animals from the previous experiment received a 
second injection of certain of the adrenergic agents and 10 mg/kg of 
egg albumin intramuscularly. The purpose of this study was to deter­
mine if the agents can influence antibody production quantitatively 
or qualitatively when they are given together with a tertiary anti­
genic stimulation. Propranolol and antigen were injected at the same
TABLE 6
EFFECTS OF ADRENERGIC AGENTS ON HOMOCYTOTROPIC ANTIBODY FORMATION
Number of Animals Responding/Number of Animals 
in the Group (Mean PCA Log^ Titer)
Days Post-Immunization
Agent 0 7 14 21 28*^ 35 42 49
None 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
Propranolol 
20 mg/kg
0/5 4/5(3) 5/5(2.4) 4/5(3.5) 4/4(6.5) 2/4(5) 3/4(2) 3/4(8)
Phenoxyben— 
zamine 
20 mg/kg
0/5 2/5(1) 3/5(4. 7) 3/5(4.7) 4/5(6) 3/5(3) 4/5(3.5) 4/5(5)
Sotalol 
20 mg/kg
0/5 0/5 0/5 0/5 0/5 0/5 1/5(0) 0/5
Norepinephrine 
120 micrograms/kg
0/4 0/4 0/4 0/4 0/4 1/4(4) 1/4(4) 1/4(4)
Isoproterenol 
50 micrograms/kg
0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
Log2  Antibody Titer = -Log^ of the highest serum dilution showing evidence of antibody 
activity. For convenience, sera without detectable activity were assigned a titer of —1.
^ Mean calculated for responders only.
^ Egg albumin, 4 mg/kg, injected into the footpads.
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TABLE 7
EFFECTS OF ADRENERGIC AGENTS ON HEMAGGLUTINATING ANTIBODY FORMATION
Mean and Range of Logg PHA Titer 
Days Post-Immunization
a
Agent 0 7 14 21 28^ 35 42 49
None -1 6.5
(3-10.5)
5.2
(4-7)
4
(2-6)
2.6
(2-4)
12.4
(11-14)
11
(9-12)
7.9
(7-8-5)
Propranolol -1 9 9.6 8.9 7.5 13.8 11.9 10.4
20 mg/kg (8-10) (8-11) (8-11.5) (6-0) (11-15) (11.5-12) (9.5-11.5)
Phenoxy­ -1 7 7 6.6 5.6 14.4 14.8 12.5
benzamine 
20 mg/kg
(1-10) (5-9) (4-9) (3-7) (14-16) (12-19) (8.5-16)
Sotalol -1 8 5.6 5.2 3.6 14.8 10.8 8.7
20 mg/kg (6-12) (4-7) (4-7) (2-6) (12-18) (9-14) (7-10)
Norepinephrine -1 6 5.3 3.9 2.8 11 9.9 8
120 micrograms/kg (3-9) (3-7) (2.5-6) (2-4) (10-12) (7-12) (7-10)
Isoproterenol -1 7.9 5.5 4.8 3.3 14 11 8.9
50 micrograms/kg (7-8) (5-6) (4-6) (2-4) (12-19) (9.5-13) (7-10)
activity.
^ Logg Antibody Titer - -Log^ of the highest serum dilution showing evidence of antibody 
For convenience, sera without detectable activity were assigned a titer of -1.
albumin, 4 mg/kg, injected into the footpads.
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site or at separate sites. Isoproterenol was injected either with or 
without egg albumin. Because the phenoxybenzamine was dissolved in 
ethyl alcohol, the effect of ethyl alcohol when injected with antigen 
on antibody production was also evaluated.
Results of this experiment are shown in Table 8. One animal 
which received propranolol and egg albumin in the same site responded 
with homocytotropic antibody production. A log^ antibody titer of 
six was detected 14 days after immunization. One animal which re­
ceived egg albumin suspended in ethyl alcohol began producing homo­
cytotropic antibody on day 14 also. Isoproterenol with egg albumin, 
propranolol and egg albumin at separate sites or egg albumin alone 
did not initiate homocytotropic antibody production. One animal in­
jected with isoproterenol alone had a 16-fold decrease in PCA anti­
body activity during the first week after treatment. All animals 
responded with increases in PHA antibody titers, including an iso­
proterenol treated animal which received no egg albumin.
The effect of varying the dosage of phenoxybenzamine and 
propranolol was studied next. Twenty-five mg/kg of egg albumin, 
along with 40, 4.0 or 0.4 mg/kg of phenoxybenzamine or 20, 2.0 or 
0.2 mg/kg of propranolol, were injected into the footpads of groups 
of rabbits. In the 20 mg/kg propranolol group, 3 of 5 animals were 
producing homocytotropic antibody by day 10, with a mean titer of 
1.6 (Tables 9 and 10). By day 20 all of the animals in this group 
had responded, with a mean titer of 4.4. The animals receiving 2.0 
and 0.2 mg/kg did not produce homocytotropic antibody. In the phen­
oxybenzamine groups, 1 of 4 animals receiving 4.0 mg/kg and 2 of 4
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TABLE 8
EFFECT OF A SECOND INJECTION OF ADRENERGIC AGENT AND ANTIGEN 
ON ANTIBODY FORMATION IN THE RABBIT
Weeks After 
Agent Second
Injection
No. of 
Animals 
With PCA 
Antibody/ 
No. in Group
Mean &
Range of PCA
Logg Titer&'b
Mean & 
Range of 
PHA Titer&
Propranolol 0 0/4 -1 8(7-10)
and Antigen, 1 0/4 -1 14(12-17)
Same Site 2 1/4 6 11.6(10-14)
Isoproterenol 0 1/3 4 10.8(9.5-12)
and Antigen, 1 1/2 4 12
Same Site 2 1/2 4 11
Isoproterenol, 0 1/1 6 8.5
No Antigen 1 1/1 2 12
2 1/1 2 10
Ethyl Alcohol 0 1/4 4 7.9(7-8.5)
and Antigen, 1 1/3 2 8.8(6-13)
Same Site 2 2/3 2(2) 9.3(6-14)
Propranolol 0 0/4 -1 8.9(7-10)
and Antigen, 1 0/4 -1 14.8(11-18)
Separate Sites 2 0/4 -1 12.3(11-14)
Antigen, 0 2/7 5(4-6) 10.6(7-16)
Alone 1 2/7 5(4-6) 15(12-17)
2 2/7 5(4-6) 11.4(11-12)
^ Log2  Antibody Titers = -Log2  of the highest serum dilution 
showing evidence of antibody activity. For convenience, sera with­
out detectable activity were assigned a titer of -1.
 ^Mean and range calculated for responders only.
 ^Agent dosages: 1) antigen-egg albumin, 10 mg/kg, 2) Pro­
pranolol-20 mg/kg, 3) Isoproterenol, 75 micrograms/kg, 4) Ethyl al­
cohol, absolute,-1 ml.
TABLE 9
EFFECT OF VARYING THE DOSAGE OF PROPRANOLOL AND PHENOXYBENZAMINE
ON THE IMMUNE RESPONSE IN RABBITS
Agent
Number of Animals Responding^’^ /Number 
Days Post-Immunization
■ in Group
0 5 7 10 14 15 20 21
Propranolol
^  ÏL a ^ ^  b a b a b
20 mg/kg 0/5 0/5 0/5 5/5 3/5 5/5 4/5 5/5 5/5 5/5
2.0 mg/kg 0/5 0/5 0/5 5/5 0/5 5/5 0/5 5/5 0/5 5/5
0.2 mg/kg 0/5 0/5 0/5 2/5 0/5 5/5 0/5 5/5 0/5 5/5
Phenoxybenzamine
a ^ â. b b
40 mg/kg 0/3 0/3 0/3 0/3 0/3 0/3 1/3 2/3
4.0 mg/kg 0/3 0/3 1/4 4/4 3/4 4/4 1/4 4/4
0.4 mg/kg 0/3 0/3 2/4 4/4 4/4 4/4 3/4 4/4
•p-
PCA antibody
Hemagglutinating antibody
TABLE 10
EFFECT OF VARYING THE DOSAGE OF PROPRANOLOL AND PHENOXYBENZAMINE ON PASSIVE
CUTANEOUS ANAPHYLAXIS ANTIBODY FORMATION IN THE RABBIT
Agent
Mean and Range of Logg Antibody 
Days Post-Immunization
Titer^'b
0 5 7 10 14 15 20 21
Propranolol
20 mg/kg -1 -1 1.6(2-4) 2.4(2-4) 4.4(2-6)
2.0 mg/kg -1 -1 -1 —1 —1
0.2 mg/kg -1 -1 -1 -1 -1
Phenoxyb en z amine
40 mg/kg -1 -1 -1 2(2)
4.0 mg/kg -1 0(0) 4(0-6) 4(4)
0.4 mg/kg -1 2.5(2-3) 3(0-4) 5.3(4-6)
4>
Ln
Log2  antibody titer = -Logg of the highest serum dilution showing evidence of antibody 
activity. For convenience, sera without detectable activity were assigned a titer of -1.
Number of animals per group: 1) Propranolol-five, 2) Phenoxybenzamine-40 mg/kg, three.
4.0 and 0.4 mg/kg, four each.
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animals receiving 0.4 mg/kg were producing homocytotropic antibody by 
day 7. Mean log^ titers were 0 and 2.5, respectively. By day 14,
3 of 4 animals receiving 4.0 mg/kg and 4 of 4 receiving 0.4 mg/kg had 
responded. Mean log2  titers were 4 and 3, respectively. No antibody 
was detected in the group receiving 40 mg/kg until day 21, the last 
day of the experiment, when a single animal had a titer of 2. All 
animals receiving propranolol were producing PHA antibodies by day 10. 
All of the phenoxybenzamine treated animals, except the group receiving 
40 mg/kg had responded by day 7. Only 2 of 3 animals in the later 
group were producing hemagglutinating antibodies by day 21, and the 
maximum mean logg antibody titer observed in this group was rather 
low (Table 11). PHA antibody titers were highest in the 20 mg/kg 
propranolol group and the 0.4 mg/kg phenoxybenzamine group. The immu­
nosuppressive effect of 40 mg/kg of phenoxybenzamine is quite evident.
Attempt to Define Mechanisms of Phenoxybenzamine 
and Propranolol Action
To determine if the adjuvant effect of propranolol and phe­
noxybenzamine was due to a decrease in cAMP levels, dibutyryl cAMP 
was administered at a dosage of 44 mg/kg into the footpads of a group 
of rabbits 30 minutes prior to immunization. Control animals not re­
ceiving dibutyryl cAMP were injected with 0.25 ml of saline per foot­
pad. The animals were immunized with egg albumin, 25 mg/kg, and 
either propranolol, 20 mg/kg, or phenoxybenzamine, 0.4 mg/kg. Control 
animals received egg albumin alone, egg albumin and dibutyryl cAMP, 
egg albumin and phenoxybenzamine or egg albumin and propranolol.
Two of five rabbits receiving propranolol and dibutyryl cAMP
TABLE 11
EFFECT OF VARYING THE DOSAGE OF PROPRANOLOL AND PHENOXYBENZAMINE
ON THE FORMATION OF HEMAGGLUTINATING ANTIBODY IN RABBITS
Mean and Range of Log^ Antibody Titers^ 
of Responding Animals
Days Post-Immunization
Agent 0 5 7 10 14 15 :20 21
Propranolol
20 mg/kg -1 3.8(2-5) 8(7-9) 7.4(6-9) 7.7(6-9.5)
2.0 mg/kg -1 3.6(2-5) 6.4(5-7) 5.3(4-6) 5.4(4-6)
0.2 mg/kg -1 1(0-3) 4(3-6) 4.4(2-6) 5.2(4-6)
Phenoxybenzamine
40 mg/kg -1 -1 -1 3.3(1-5)
4.0 mg/kg -1 5.5(1-8) 7(6-9) 6.1(5-7)
0.4 mg/kg -1 9.5(8-14) 8.8(8-11) 8.5(6-11)
Logg antibody titer = -Log of the highest serum dilution showing evidence of anti­
body activity. For convenience, sera without detectable activity were assigned a titer of -1.
Number of animals per group: 1) Propranolol-five each dosage, 2) Phenoxybenzamine- 
40 mg/kg, three, 4.0 and 0.4 mg/kg, four each.
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were producing homocytotropic antibody on day 7 with a mean titer of 4 
(Table 12). The other groups receiving adrenergic agents all contained 
animals producing homocytotropic antibody by day 14. All animals re­
sponded with PHA antibody production by day 7 (Table 13). The mean 
antibody titer for the phenoxybenzamine treated group was lower than 
that of the other groups, however the animals which received phenoxy­
benzamine and dibutyryl cAMP had a mean titer on day 14 approximately 
equal to that of the group receiving egg albumin alone. Mean antibody 
titers for the groups receiving propranolol alone, propranolol and 
dibutyryl cAMP and dibutyryl cAMP alone remained high on day 14, or 
increased slightly. This experiment was terminated on day 14 because 
of the deaths of a large number of animals due to unknown causes.
Titration of Skin Test Materials 
A rabbit immunized three weeks previously with egg albumin,
25 mg/kg, and propranolol, 20 mg/kg, by footpad injections, received 
intradermal injections of 0.1 ml volumes of the following test mater­
ials: 1) Histamine, 0.0055 to 5,500 micrograms/0.1 ml in tenfold in­
crements, 2) Egg albumin, 0.01 to 10,000 micrograms/O.l ml in tenfold 
increments, and 3) Bovine serum albumin, 0.01 to 10,000 micrograms/
0.1 ml in tenfold increments. Following the series of injections the 
animal was given an intravenous injection of 2 ml of Evan's Blue dye. 
One hour later the areas of bluing were measured through the skin and 
recorded as described above. The results are given in Table 14. The 
concentrations selected for further studies were histamine, 0.55 micro­
grams/0.1 ml, egg albumin, 10 micrograms/0.1 ml, and bovine serum al­
bumin, 10 micrograms/0.1 ml. It was felt that these intermediate
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TABLE 12
EFFECTS OF DIBUTYRYL CYCLIC-AMP AND ADRENERGIC AGENTS ON 
HOMOCYTOTROPIC ANTIBODY FORMATION IN THE RABBIT
Number of Responding Animals/Number 
of Surviving Animals, Mean PCA Titer 
of Responding Animals^
Days Post-Immunization
Agents^ 0 7 14
Saline 0/3 0/3 0/2
Propranolol 
20 mg/kg
0/3 0/3 2/3, 5(4-6)C
Propranolol 
20 mg/kg & 
diB c-AMP 
44 mg/kg
0/5 2/5, 4(4) 3/5, 4(2-6)
Phenoxyben­
zamine 
0.4 mg/kg
0/3 0/3 1/1, 2
Phenoxyben­
zamine 
0.4 mg/kg & 
diB c-AMP 
44 mg/kg
0/5 0/5 1/3, 4
diB c-AMP 
44 mg/kg
0/5 0/5 0/2
^ Logg Antibody Titer = -Log2 of the highest serum dilution 
showing evidence of antibody activity. For convenience, sera without 
detectable activity were assigned a titer of -1.
b
albumin.
All animals received the indicated drug plus 25 mg/kg egg
Number in parenthesis indicates range of antibody titers 
within a group.
TABLE 13
EFFECTS OF DIBUTYRYL CYCLIC-AMP AND ADRENERGIC AGENTS ON 
HEMAGGLUTINATING ANTIBODY FORMATION IN THE RABBIT
Number of Responding Animals/Number of 
Surviving Animals, Mean PHA Titer of 
Responding Animals^
Days Post-Immunization
Agent^ 0 7 14
Saline 0/3 3/3, 8.2(5.5-11) 2/2, 5(3-7)
Propranolol, 20 mg/kg 0/3 3/3, 9(7-12) 3/3, 8.3(7-10)
Propranolol, 20 mg/kg & 
diB c-AMP, 44 mg/kg
0/5 5/5, 9.8(9-11) 4/4, 9.5(7-11)
Phenoxybenzamine, 
0.4 mg/kg
0/3 3/3, 3.2(2-5) 1/1, 1
Phenoxybenzamine,
0.4 mg/kg &
diB c-AMP, 44 mg/kg
0/5 5/5, 5.3(2-8.5) 3/3, 5.7(1-9)
diB c-AMP, 44 mg/kg 0/5 5/5, 8.1(4-11) 2/2, 8.5(8-9)
LnO
® Log2  Antibody Titer = -Logg of the highest serum dilution showing evidence of anti­
body activity. For convenience, sera without detectable activity were assigned a titer of -1.
^ All animals received the indicated drug and 25 mg/kg egg albumin.
Number in parenthesis indicates range of antibody titers within a group.
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TABLE 14
TITRATION OF EGG ALBUMIN, BOVINE SERUM ALBUMIN AND HISTAMINE 
BY DIRECT SKIN TEST OF A SENSITIZED RABBIT
Dosage, microgram^ Diameter of Bluing, mm
Histamine
Egg Albumin
Bovine Serum 
Albumin
5,500 15
550 12
55 12
5.5 10
0.55 7
0.055 .5
0.0055 3
10,000 20
1,000 17
100 9.5
10 8
1 6.5
0.1 4
0.01 3
10,000 5
1,000 3
100 10
10 5
1 0
0.1 0
0.01 0
Amount injected in 0.1 ml volume.
Average of two measurements, in millimeters, of the dia­
meter of bluing.
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doses would allow detection of both increased and decreased reactivity.
Effects of Propranolol on the Direct Skin Test 
and the Reaction to Histamine
A group of rabbits which had been immunized as described pre­
viously, were tested, by direct skin test, for their immediate hyper­
sensitivity response to egg albumin, 10 micrograms/O.l ml, bovine 
serum albumin, 10 micrograms/O.l ml, and to histamine, 0.55 micrograms/ 
0.1 ml, before and 30 minutes after the injection of propranolol, 20 
mg/kg.
The results are given in Table 15. Propranolol treatment in 
many cases seemed to lessen the response to egg albumin as evidenced 
by a decrease in diameter of the area of bluing. The response to his­
tamine was also decreased in a number of animals, but to a lesser ex­
tent. The response to BSA and saline was not affected. There is no 
correlation between homocytotropic or hemagglutinating antibody titers 
and the diameter of the skin reaction. Many animals which did not 
have detectable antibody had positive skin reactions to egg albumin.
Tests for Blocking Antibody
These procedures were developed to test the possibility some 
class of antibody might block immediate hypersensitivity by occupying 
tissue sites competitively. Sera, collected on day 0, 7, 28 and 49 
from animals immunized as described previously with adrenergic agents 
and egg albumin, were injected into the skin of a rabbit sensitized to 
egg albumin. Thirty minutes later, following the intravenous injec­
tion of Evan’s Blue dye, 0.1 ml of egg albumin (10 micrograms) was in­
jected into each site. One hour later the rabbit was killed and the
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TABLE 15
EFFECT OF PROPRANOLOL ON SKIN TEST REACTIONS IN RABBITS 
IMMUNIZED WITH EGG ALBUMIN
Skin Test Material
Diameter of Bluing, Before^ and After Propranolol
Animal PCA PHA EA BSA Histamine Saline
Number Titer* Titer* c d c d c d c d
2 6 20 7 2 I 15 18 I 0
3 6 16 II 2 3 16 15 I 0
4 8 18 10 2 2 18 15 2 0
5 5 10 18 10 8 25 20 20 20
6 5 20 18 2 2 20 18 2 2
7 10 15 II 2 2 16 18 0 0
8 4 14 12 2 2 10 10 0 0
9 6 18 17 I I 7 5 I 0
10 4 15 8 2 I 18 14 0 0
12 2, 8 15 12 0 0 20 18 0 0
13 5 5 5 2 2 24 23 0 0
14 6 23 12 I I 5 18 0 0
15 7 15 II 2 I 10 10 2 0
16 6 2 2 I 2 20 16 2 0
17 10 6 5 22 20 9 10 0 0
18 4 II 2 I 20 15 I 10 0 0
^ Logg Titers, where -I = no reaction; 0 = positive with un­
diluted serum.
^ EA = egg albumin, 10 micrograms; BSA = bovine serum albumin, 
10 micrograms; Histamine, 0.55 micrograms; saline = 0.85% NaCI. All 
materials were injected intradermally in 0.1 ml volume.
Average of two measurements, in millimeters, of the diam­
eter of bluing.
Average of two measurements, in millimeters, of the diameter 
of bluing at a second site, 30 minutes after the footpad injection of 
propranolol, 20 mg/kg of body weight.
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areas of bluing were recorded as described previously.
The results are given in Table 16. There was no evidence 
that adrenergic drugs stimulate the production of blocking antibodies, 
at least as measured by this test.
In another experiment undiluted serum was injected into the 
skin of a sensitized rabbit as described previously. The prepared 
sites and uninjected sites were challenged at 6, 22, or 41 hours 
with egg albumin, 10 micrograms/0.1 ml. Increasing the time between 
serum injection and challenge with egg albumin did not affect the 
skin test response (Table 17). No inhibition of the skin test re­
sponse to egg albumin could be shown.
In Vitro Binding of Egg Albumin 
Sera from PCA negative rabbits were tested for their ability 
to bind egg albumin in vitro. Serum, undiluted and diluted 1:10 with 
0.85% NaCI was mixed with an equal volume of egg albumin, 200 micro­
grams/ml, and allowed to stand at 4° C for 4 or 24 hours. The serum- 
egg albumin mixtures, egg albumin, serum, and saline were injected 
into the skin of a sensitized rabbit as described previously. No 
differences in the immediate hypersensitivity reactions compared with 
that produced by egg albumin alone were noted. There was no reaction 
or very slight response (1-5 mm) to serum alone or saline. The diam­
eters of the areas of bluing in response to egg albumin, and undiluted 
or diluted serum-egg albumin mixtures were from 10 to 15 mm. Sera 
from all the bleedings (day 0, 7 and 63) and from both rabbits gave 
approximately the same results.
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TABLE 16
THE EFFECTS OF ADRENERGIC AGENTS ON THE DEVELOPMENT OF BLOCKING 
ANTIBODY FOR THE IMMEDIATE SKIN TEST REACTION TO EGG ALBUMIN
Day of Serum Collection 
Diameter of Bluingd .
Agent^
Serum
Number
0
b c b
7
c b
28
c
49
b c
Saline 1 8 7 9 8 6 5 5 6
2 8 7 9 6 8 9 8 8
Sotalol, 1 9 10 9 9 7 9 7 8
20 mg/kg
2 9 7 8 9 7 7 5 8
Norepinephrine, 1 8 6 8 7 8 7 7 8
120 micrograms/
kg 2 7 8 8 8 9 9 7 8
Isoproterenol, 1 8 6 6 8 7 8 7 7
50 micrograms/
kg 2 7 6 8 8 6 7 8 8
All the animals were immunized with the indicated drug and 
egg albumin, 25 mg/kg in the footpads; a second injection of egg albu­
min was given in the footpads on day 28.
^ Undiluted serum.
of bluing.
Serum diluted 1:5 in 0.85% NaCI.
Average of two measurements, in millimeters, of the diameter
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TABLE 17
EFFECT OF PRIOR INTRADERMAL INJECTION OF HYPERIMMUNE, 
PCA NEGATIVE SERUM ON THE SKIN TEST REACTION 
IN SENSITIZED RABBITS
Period of Fixation Prior to 
Challenge of Iniected Site Diameter of Bluing in Millimeters
Hours Serum Injected Site Normal Site
Js 11 10
6 8 9
22 8.5 10
41 10 9
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Physicochemical Properties of Antibodies from Phenoxybenzamine 
and Propranolol Treated Animals
The heat stability, mercaptoethanol sensitivity and latent 
period required for skin fixation of the homocytotropic antibody were 
studied. Serum pools from early and late bleedings were prepared for 
both propranolol and phenoxybenzamine treated groups. Heating at 
56° C decreased PCA activity but did not markedly lower hemagglutina­
tion titers (Table 18). Complete inactivation of the PCA activity of 
sera collected on day 7 was accomplished in two hours while sera col­
lected on day 49 still gave a positive reaction when injected undil­
uted. The magnitude of the decrease in titer was about the same for 
both early (day 7) and late (day 49) sera.
Reduction with 2-mercaptoethanol followed by alkylation with
0.02 M iodoacetamide completely inactivated the homocytotropic anti­
body, lowering titers from 1 or 2 to -1 (Table 19). Passive hemag­
glutination titers of sera collected on day 7 were similarly reduced 
from 7 to 1 or 2. Day 49 PHA titers were not lowered by this treat­
ment.
PCA reactions were obtained when antigen was given as early 
as 24 hours after the injection of serum (Table 20). These reactions 
were faint and usually confined to undiluted serum. At 48 and 72 
hours, reactions were obtained with more dilute sera. No difference 
could be found in the sera from propranolol treated and phenoxybenza­
mine treated animals.
58
TABLE 18
EFFECTS OF HEAT ON ANTIBODY TITER IN SERUM FROM RABBITS 
RECEIVING PROPRANOLOL OR PHENOXYBENZAMINE AT THE 
TIME OF IMMUNIZATION
Group
Day of Serum 
Collection
Hours
Heated
PCA Titer^ PHA Titer*
Propranolol 7 0 1 9
1 0 9
2 -1 9
4 -1 9
49 0 2 13
1 1 13
2 1 12
4 0 12
Phenoxyben­ 7 0 0 13
zamine 1 0 13
2 -1 12
4 -1 12
49 0 2 20
1 1 19
2 1 17
4 0 16
Log2 Antibody Titer = -Logg of the highest serum dilution 
showing evidence of antibody activity. For convenience, sera with­
out detectable activity were assigned a titer of -1.
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TABLE 19
EFFECT OF REDUCTION AND ALKYLATION ON ANTIBODY 
TITERS IN RABBITS RECEIVING ADRENERGIC AGENTS 
AT TIME OF IMMUNIZATION
Mixture
Injected
Day of 
Serum 
Collection
Logg PCA Titer
Before After 
Red. & Alk.o
Logg PHA Titer°
Before Af|er
Red. & Aik.
Propranolol 
20 mg/kg &
7 2 -1 7 1
egg albumin 
25 mg/kg
49 1 -1 12 12.5
Phenoxyben­
zamine
7 2 -1 7 2
0.4 mg/kg & 
egg albumin 
25 mg/kg
49 2 -1 13.5 11.5
Log Antibody Titer = -Logg of the highest serum dilution 
showing evidence of antibody activity. For convenience, sera with­
out detectable activity were assigned a titer of -1.
^ Red. & Aik. = Reduction with 0.1 M 2-mercaptoethanol for 
3 hours followed by alkylation with 0.02 M iodoacetamide for 4 hours.
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TABLE 20
LATENT PERIOD REQUIRED FOR SKIN FIXATION OF HOMOCYTOTROPIC 
ANTIBODY IN THE RABBIT
Mixture Injected
Day of 
Serum 
Collection
Logg PCA Antibody Titer^ 
Hours Post Serum Injection
24 48 72
Propranolol, 20 mg/kg 7 0 1 3
& Egg Albumin, 25
mg/kg 49 1 2  2
Phenoxybenzamine, 7 - 1 1 2
20 mg/kg &
Egg Albumin, 25 mg/kg 49 0 1 2
® Log2  Antibody Titer = -Logg of the highest serum dilution 
showing evidence of antibody activity. For convenience, sera with­
out detectable activity were assigned a titer of -1.
CHAPTER IV
DISCUSSION
Adrenergic drugs have been reported previously to both en­
hance and suppress the immune response (53-61). The present study 
confirms these reports and presents new data on the effects of adren­
ergic blockade on homocytotropic antibody formation.
An increase in cAMP levels either as the result of isopro­
terenol stimulation or by endogenous cAMP dynamics has been reported 
to both suppress and enhance antibody formation (55, 58, 59). Simi­
lar findings have been noted for the alpha adrenergic stimulator, 
norepinephrine, which depresses cAMP levels (56, 57). In the present 
study, neither of these drugs appeared to influence the production 
of PHA antibodies for egg albumin. This could have been the result 
of a suboptimal drug dosage or period of drug exposure. In the study 
of Reed e^ (55), which revealed an immunosuppressive effect for 
isoproterenol and epinephrine, the drugs were given at 8 and 6 hour 
intervals for 10 days.
The immunological adjuvanticity of propranolol when admin­
istered at dosages of 5 to 20 mg/kg of body weight at the time of 
antigen exposure is confirmed in the present study. Titers of PHA 
antibody achieved with propranolol were exceeded only by those
■ a
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obtained with complete Freund's adjuvant (CFA). Antibody titers de­
clined much more slowly in the propranolol- and CFA-treated groups.
The response of propranolol-treated animals to a second injection of 
antigen was not different from that of animals treated with other 
adrenergic agents.
For the first time, propranolol has been demonstrated to be 
an adjuvant for homocytotropic antibody formation. The reason for 
this rests probably with the timing and duration of the treatment 
with propranolol. In previous studies, propranolol was given for a 
period of 10 days after immunization. Failure to enhance homocyto­
tropic antibody formation by long term beta adrenergic blockade seems 
inconsistent with the theory of Szentivanyi (20). It is possible, 
however, that beta blockade in the atopic individual involves only 
a specific cell type participating in the immune response. If so, 
a single injection of propranolol, as used in the present study, 
might reproduce this selective block. Such a selective blockade 
might not be invoked by the administration of propranolol for a long­
er period of time. Exposure to propranolol at the time of antigen 
injection apparently influences cells involved in the initiation of 
the immune response without being inhibitory for later cell functions.
The immune response is thought to involve interactions among 
three types of cells (120). These include macrophages, which may 
concentrate antigen or present antigen to lymphocytes for immune rec­
ognition, and lymphocytes. Lymphocytes are thought to be of at least 
two types, antigen-reactive cells which process antigen in some fash­
ion and antibody forming cells. Beta adrenergic blockade at the time
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of immunization could cause the proliferation of any one, or all three 
of these cell types. Beta adrenergic blockade might alter the function 
of these cell types. These events are most likely related to cellular 
cAMP levels.
Shepard (121) has reported that transformed cells have lower 
cAMP levels than normal cells and that agents which decrease cellular 
cAMP levels stimulate growth. Such findings suggest that biochemical 
events which involve high concentrations of cAMP promote cellular dif­
ferentiation and that the lowering of cAMP levels allows events asso­
ciated with cell proliferation to proceed.
Hadden et^  (122) found that the phytohemagglutinin and 
concanavalin A initiated proliferation of peripheral blood lymphocytes 
is accompanied by a ten to fiftyfold increase in guanosine S’: 5'- 
cyclic monophosphate (cGMP) concentration in the cells. No changes 
in cAMP levels were noted. Strom et (123) noted an increase in 
cGMP levels following the addition of cholinergic agents to rat lymph­
ocytes vitro. The interrelationship of cAMP and cGMP is not known, 
but Franks and MacManus (124) reported that the hydrolysis of cAMP by 
phosphodiesterase is enhanced by cGMP ^  vitro.
Whatever the mechanism by which beta adrenergic blockade en­
hances immunoglobulin production, the cells involved in homocytotropic 
antibody formation appear to be most affected. Reed (125) has pro­
posed that adrenergic blockade in atopic individuals involves the 
cells which produce IgE.
The beta adrenergic blocking drug Sotalol did not exert an 
adjuvant effect on the primary immune response. However, homocytotropic
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antibody was detected in a single rabbit on day 42 after a second in­
jection of egg albumin (Table 6). Lack of adjuvanticity may be re­
lated to the dosage administered or to the fact that Sotalol is a 
more selective blocking agent. Sotalol appears to block the beta-1 
subtype of beta receptors. This receptor mediates inotropic, chrono­
tropic, cardiac and lipolytic effects. Propranolol blocks both beta-1 
and beta-2 mediated effects, and it is possible that a beta-2 receptor 
is more involved with homocytotropic antibody production. It has 
been postulated that the beta-2 receptor responses are impaired in 
atopic disease (125).
A single norepinephrine treated animal also began producing 
homocytotropic antibody after a second antigen injection (Table 6).
Since norepinephrine also lowers cAMP levels, but by a different mech­
anism than propranolol, it may have influenced an early event in the 
immune response, leading to enhancement of homocytotropic antibody 
formation on second exposure to antigen.
The most interesting and puzzling finding in the present 
research is that phenoxybenzamine, an alpha adrenergic blocking agent, 
is also an adjuvant for both PHA and homocytotropic antibody formation. 
Pieroni and Levine (61) had previously reported that a dosage of approx­
imately 40 mg/kg was immunosuppressive in mice. However, dosages of 3 
mg/kg (53) and 0.2 to 0.5 mg/kg (62) (the human therapeutic equivalent) 
were reported not to affect the humoral immune response in the rabbit.
In the present study, 0.4 mg/kg of phenoxybenzamine was found to be a 
better adjuvant than 20 mg/kg of propranolol for both homocytotropic 
and PHA antibody formation. As the dosage of phenoxybenzamine was
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increased, an effect was noted which was more one of delay than sup­
pression. Even at a dosage of 40 mg/kg, when none of the animals had 
a detectable antibody titer on day 14, 1 of 3 had a homocytotropic 
antibody titer and 2 of 3 had PHA antibody titers on day 21 (Table 
10).
Phenoxybenzamine does not block beta adrenergic receptors.
The fact that it enhances homocytotropic antibody formation without 
causing a beta blockade suggests either that it lowers cAMP levels 
through another mechanism or that cAMP is not the compound which is 
mediating the effect. Both alpha and beta blockade should tend to 
increase ATP levels. Alpha blockade is related to ATPase inhibition 
and beta blockade interferes with the conversion of ATP to cAMP. How 
modification of ATP utilization might increase homocytotropic anti­
body formation is not known. A second compound which may be important 
is cGMP. It is also possible that homocytotropic antibody formation 
could be regulated by two or more separate compounds, acting either 
through the same of through different mechanisms. The studies of 
Hadden et al. (122) correlated the mitogenic effects of PHA and con­
canavalin A with an increase in cGMP levels, accompanied by no change 
in cAMP levels. The results suggested that an increase in cGMP may 
represent a signal that induces cell division, while an increase in 
cAMP inhibits cell division. The important thing may not be the actual 
concentrations of the two compounds but their relative proportions.
This balance could be upset by a beta block which would lower cAMP 
or by cholenergic stimulation which increases cGMP levels (123). 
Phenoxybenzamine has been reported to have certain anticholinergic
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effects (126). Further studies will be needed to clarify the roles 
of both cholinergic and adrenergic receptors in the immune response.
Tada et (127-131) have postulated that two mechanisms 
are involved in the control of homocytotropic antibody formation in 
rats, namely (a) the presence of IgG antibodies at the time of anti­
genic stimulation or after antigenic stimulation inhibits homocyto­
tropic antibody formation, and (b) thymus-dependent cells have a dual 
role in the formation of homocytotropic antibody, i.e. they are re­
quired during the early events and are suppressive during later events 
in the differentiation and function of homocytotropic antibody forming 
cells.
The observed effects of alpha and beta blocking agents fit 
nicely into these postulates, assuming that T and B cells have dif­
ferent adrenergic requirements. For instance, beta adrenergic block 
might enhance homocytotropic antibody formation directly by stimulat­
ing the activity of B cells, while alpha adrenergic blockade might 
accomplish the same thing indirectly by enhancing the early, or in­
hibiting the late activities of T cells which influence homocytotropic 
antibody formation. Other possibilities exist with these hypothetical 
mechanisms, but further experimentation would be required to confirm 
or deny them.
In the present studies an attempt was made to inhibit the 
adjuvant effect of beta and alpha adrenergic blockade by the admin­
istration of dibutyryl cAMP prior to injection of the adrenergic agent 
and antigen. Dibutyryl cAMP appeared to enhance the adjuvanticity of 
both propranolol and phenoxybenzamine for homocytotropic antibody
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formation. This could be the result of an increase in phosphodiester­
ase activity in response to the dibutyryl cAMP which, when followed 
by beta blockade, would lower cAMP levels even further. How this would 
also increase the effects of alpha blockade is not known.
The effects of a second injection of adrenergic agent and 
egg albumin on PHA and homocytotropic antibody formation were also 
studied. Isoproterenol and antigen did not lower homocytotropic anti­
body titers. Isoproterenol alone had an adjuvant effect on PHA anti­
body formation while lowering the homocytotropic antibody titer. Pro­
pranolol and egg albumin administered together at the same site ini­
tiated homocytotropic antibody formation, while the two compounds in­
jected at separate sites did not (Table 8). This suggests that local 
effects, possibly relating to propranolol concentration, are important 
in establishing adjuvanticity. The effect of alcohol on homocytotropic 
antibody formation is interesting since it seemed to lower the anti­
body titer in one animal and initiate antibody production in another 
animal (Table 8). This study is difficult to interpret because of 
the small number of animals in certain groups and the differences in 
adrenergic treatment during primary immunization.
Propranolol did not enhance the immediate skin test reaction 
to egg albumin or histamine (Table 15). The in vitro antigen-induced 
histamine release from sensitized human leukocytes has been shown to 
be inhibited by compounds which increase cellular cAMP levels (132).
One of these inhibitory compounds is histamine. It can be postulated 
that the histamine liberated by the mast cells in response to the 
first injection of egg albumin was able to inhibit, to a certain
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extent, the histamine release by other mast cells. The beta blockade 
produced by propranolol was not sufficient to overcome this inhibition 
and result in a larger skin reaction. The response to histamine should 
remain the same since there is no information that the actions of this 
drug are mediated through the adrenergic receptors. No correlation 
was found between skin test response and homocytotropic antibody titers 
(Table 15). Most of the animals gave a positive response to egg albu­
min, even though their serum did not have PCA antibody. This suggests 
that homocytotropic antibody normally attaches to mast cells as rapid­
ly as it is formed and that only the excess is found in the serum.
No evidence was found for a "blocking" antibody which could 
bind to egg albumin either vitro or i^ vivo and prevent the imme­
diate skin test response (Tables 16, 17). This is not unexpected 
since these antibodies are usually found only after a considerable 
number of antigen injections.
The physiochemical properties of the homocytotropic antibody 
did not differ remarkably from those reported previously for this anti­
body in rabbits (117). The antibodies from both propranolol- and 
phenoxybenzamine-treated animals appeared to be the same. The se­
quence of immunoglobulin formation was normal, as evidenced by a low­
ering of PHA antibody titers following mercaptoethanol treatment of 
serum collected early, but not late in the immunization period. This 
suggested that the initial response was primarily antibody of the im­
munoglobulin class IgM, which is mercaptoethanol-sensitive. In the 
secondary response, the antibody was of the immunoglobulin class IgG, 
which is mercaptoethanol-resistant.
CHAPTER V
SUMMARY
Propranolol, a beta adrenergic blocking agent, when admin­
istered at dosages of 5 to 20 mg/kg of body weight, enhanced both 
homocytotropic (PCA) and hemagglutinating (PHA) antibody formation 
in the primary immune response of rabbits to egg albumin. No signif­
icant effect on the secondary immune response could be demonstrated. 
Phenoxybenzamine, an alpha adrenergic blocking agent, at dosages of
0.4 to 40 mg/kg, also had an adjuvant effect. A marked delay in the 
immune response was noted with high dosages of phenoxybenzamine. The 
administration of dibutyryl cAMP prior to the injection of propranolol 
or phenoxybenzamine enhanced the adjuvanticity of these compounds. 
Sotalol, a selective beta-1 adrenergic receptor blocking agent, and 
Arterenol, an alpha adrenergic stimulant, did not affect the primary 
immune response. However, following a second injection of antigen, 
homocytotropic antibody was detected in a single animal in each group. 
Isoproterenol, a beta adrenergic stimulant, had no adjuvant effect.
Treatment with propranolol 30 minutes prior to skin testing 
appeared to lessen the immediate hypersensitivity response of sensi­
tized rabbits to egg albumin and histamine. A positive skin test to 
egg albumin was demonstrated by many animals even though their serum
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did not contain homocytotropic antibody demonstrable by the homologous 
PCA reaction.
The injection of hyperimmune, PCA-negative serum into the 
skin of sensitized animals prior to skin testing with egg albumin did 
not lessen the immediate hypersensitivity response. The incubation of 
antigen with hyperimmune serum prior to injection did not affect the 
skin test response to the antigen.
Heating sera at 56° C for periods of up to 4 hours reduced 
or abolished PCA activity but did not lower PHA antibody titers. Re­
duction with 2-mercaptoethanol and alkylation with iodacetamide abol­
ished PCA antibody activity and lowered early (day 7) PHA antibody 
titers. The PHA antibody titers of sera collected on day 49 were not 
affected by this treatment.
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